Sertraline in post Stroke Depression in Irkutsk, Russia

A randomised controlled study in patients with ischemic stroke treated with antidepressant sertraline (Stimuloton) and rhythmic stimulation in Irkutsk, Russia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN60046672

Enrollment

121

Registered

2012-03-30

Start date

2006-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rehabilitation after stroke Circulatory System Stroke, not specified as haemorrhage or infarction

Interventions

1. 30 depressive patients were treated by standard treatment 2. 31 patients received this standard treatment with additional rhythmic stimulation - rhythmic stimulation was presented by light and soun

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients after ischemic stroke 2. No seizures

Exclusion criteria

Exclusion criteria: 1. Patients with sever cognitive impairments 2. Epileptic seizures

Design outcomes

Primary

Measure	Time frame
1. Lindmark Scale (LI) 2. The Hamilton Depression Rating Scale (HDRS) 3. The Hospital Anxiety Depression Scale 4. SF-36 Assessed on day of admittance of patients and on day 20 or 21 of treatment	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Russian Federation

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026